State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
The most common symptom was stomach problems but some also experienced blurred vision, depression and dizziness. Four deaths ...
Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...
U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...
Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the ...
Lars Fruergaard Jørgensen, Novo Nordisk's CEO, says his company is working to expand manufacturing to meet the supply ...
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
That same report found that the obesity fighting drug Wegovy goes for $1,349 in the U.S. compared to $140 in Germany. Norvo ...
Novo shares fell as much as 4.6% to a seven-month low on Friday after a JPMorgan Chase & Co. analyst said the Danish firm’s ...
Ozempic was approved in the US in late 2017 for diabetes, but its powerful effect on weight loss led to significant off-label use. Wegovy, the same medicine in a slightly higher dose, was approved in ...
The price of drugs Wegovy and Ozempic, which are used to treat diabetes and obesity, have come under the microscope at a US Senate hearing Americans can be charged $1,349 (£1,010) for one month ...